Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ustekinumab QoL in Psoriasis
NCT01511315Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Mar 2012
- Primary completion
- Dec 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ustekinumab in plaque psoriasis, sponsored by University of California, San Francisco. Started Mar 2012; status: completed.
02
Drugs
ustekinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01511315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01511315.